Select Keyboard:
Türkçe ▾
  1. Türkçe
  2. English
  3. العربية
  4. Dansk
  5. Deutsch
  6. Ελληνικά
  7. Español
  8. فارسی
  9. Français
  10. Italiano
  11. Kurdî
  12. Nederlands
  13. Polski
  14. Português Brasileiro
  15. Português
  16. Русский
  17. Suomi
  18. Svenska
  19. 中文注音符号
  20. 中文仓颉输入法
X
"1234567890*-Bksp
Tabqwertyuıopğü,
CapsasdfghjklşiEnter
Shift<zxcvbnmöç.Shift
AltGr

esomeprazole

listen to the pronunciation of esomeprazole
English - English
A proton pump inhibitor used in the treatment of dyspepsia and similar disorders
(Eczacılık) Esomeprazole (IPA: ) is a proton pump inhibitor (brand names Nexium®; Lucen®; Esopral® and Axagon® in Italy) developed and marketed by AstraZeneca which is used in the treatment of dyspepsia, peptic ulcer disease (PUD), gastroesophageal reflux disease (GORD/GERD) and Zollinger-Ellison syndrome. Esomeprazole is the S-enantiomer of omeprazole (marketed as Losec/Prilosec), and AstraZeneca claims improved efficacy of this single enantiomer product over the racemic mixture of omeprazole. However, this greater efficacy has been disputed, with some claiming it offers no benefit from its older form. Esomeprazole was the third biggest selling pharmaceutical drug in the world for 2005, totaling $5.7 billion in sales for the year of 2005